SPDR S&P Biotech ETF $XBI Position Lowered by Sonata Capital Group Inc.

Sonata Capital Group Inc. lowered its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 85.8% during the third quarter, HoldingsChannel reports. The fund owned 1,925 shares of the exchange traded fund’s stock after selling 11,665 shares during the quarter. Sonata Capital Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $304,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bank of America Corp DE increased its holdings in SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares in the last quarter. Hsbc Holdings PLC boosted its stake in shares of SPDR S&P Biotech ETF by 7.8% during the fourth quarter. Hsbc Holdings PLC now owns 638,529 shares of the exchange traded fund’s stock valued at $78,049,000 after purchasing an additional 46,339 shares in the last quarter. Main Street Research LLC boosted its stake in shares of SPDR S&P Biotech ETF by 57.4% during the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock valued at $72,484,000 after purchasing an additional 206,953 shares in the last quarter. Strs Ohio grew its holdings in shares of SPDR S&P Biotech ETF by 4.9% during the first quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock worth $52,433,000 after purchasing an additional 19,300 shares during the last quarter. Finally, SG Americas Securities LLC grew its holdings in shares of SPDR S&P Biotech ETF by 41.4% during the first quarter. SG Americas Securities LLC now owns 391,243 shares of the exchange traded fund’s stock worth $49,973,000 after purchasing an additional 114,638 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock traded up $3.52 on Monday, hitting $147.84. The stock had a trading volume of 5,218,316 shares, compared to its average volume of 9,164,976. The stock has a 50 day moving average of $158.09 and a 200 day moving average of $147.07. SPDR S&P Biotech ETF has a twelve month low of $106.30 and a twelve month high of $169.89. The firm has a market capitalization of $10.21 billion, a P/E ratio of 11.47 and a beta of 0.83.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.